Navigation
The Company
Our Science
mTOR Pathway
nab
Technology Platform
Publications and Abstracts
Our Medicine
Our Medicine
Advanced Malignant PEComa
Pipeline
Patients
Overview
Patient Advocacy
Contact Us
General Contact
For Healthcare Professionals
Careers
Archive: April 17, 2023
Home
2023
April
17
17
Apr
2023
Phase 2, Multicenter Open-label Basket Trial of
nab
-Sirolimus for Patients With Inactivating Alterations in
TSC1
or
TSC2
(PRECISION I)
0
0
April 17, 2023
April 17, 2023